Zevra Therapeutics Inc (ZVRA)

R&D Expenses

$14.93M

TTM · Period ending: · USD

ZVRA logo

ZVRA R&D Expenses

Latest reported$14.93M
ZVRA TTM R&D Expenses ($11.92M → $14.93M)
High-resolution chart · PNG

ZVRA r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Zevra Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
14,930,000
13,877,000
12,743,000
20,037,000
27,550,000
34,638,000
42,095,000
42,626,000
43,978,000
40,890,000
38,830,000
17,074,000
10,162,000
25,187,000
19,614,000
33,734,000
30,588,000
10,978,000
10,161,000
10,406,000
9,876,000
8,982,000
8,843,000
8,254,000
10,161,000
13,010,000
19,415,000
23,254,000
32,968,000
38,653,000
41,759,000
40,991,000
33,954,000
28,116,000
20,593,000
23,030,000
21,024,000
21,362,000
20,482,000
17,225,000
17,266,000
15,046,000
13,931,000
15,126,217
14,051,217
12,998,217
11,917,217
6,799,904
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.